the injecting and sexual behaviour of intravenous drug users [letter; comment]

NLM AIDSLINE The injecting and sexual behaviour of intravenous drug users [letter; comment]
January 30, 1991

Med J Aust. 1990 Oct 1;153(7):433. Unique Identifier : AIDSLINE Acquired Immunodeficiency Syndrome/TRANSMISSION Australia Human HIV Infections/TRANSMISSION HIV-1 Sex Behavior Substance Abuse, Intravenous COMMENT LETTER JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused DELAWARE: Cape Henlopen Theatre Academy to Host 'Magic to Do' May 25 Zimbabwe activist: Prisoners denied AIDS drugs UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog Study Finds Vitamin C Can Kill Drug-Resistant TB Immune system cancer drugs tipped to be a $35 billion market TEXAS: Temple - Wellness and Sexual Health Classes Helping Kids to Abstain NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs NORTH KOREA: North Korea Sees Surge of Drug-Resistant Tuberculosis Experimental Gilead drug effective in early-stage leukemia trial TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events
Information in this article was accurate in January 30, 1991. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.